Niva Bupa Health Insurance Company Ltd
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
- Market Cap ₹ 14,947 Cr.
- Current Price ₹ 81.6
- High / Low ₹ 109 / 61.0
- Stock P/E 183
- Book Value ₹ 11.3
- Dividend Yield 0.00 %
- ROCE 4.85 %
- ROE 5.69 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 7.23 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of -3.86% over last 3 years.
- Earnings include an other income of Rs.329 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Insurance Industry: Finance & Investments
Part of Nifty 500 BSE SmallCap BSE Allcap BSE Financial Services BSE IPO
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 1,057 | 1,413 | 2,114 | 3,165 | 4,196 | |
| 1,094 | 1,435 | 2,374 | 3,534 | 4,413 | |
| Operating Profit | -37 | -22 | -260 | -369 | -217 |
| OPM % | -3% | -2% | -12% | -12% | -5% |
| 0 | 0 | 90 | 413 | 329 | |
| Interest | 4 | 6 | 0 | 0 | 0 |
| Depreciation | 21 | 22 | 27 | 32 | 29 |
| Profit before tax | -62 | -50 | -197 | 13 | 82 |
| Tax % | 0% | 0% | 0% | 0% | 0% |
| -62 | -50 | -197 | 13 | 82 | |
| EPS in Rs | |||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 44% |
| TTM: | 33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 54% |
| TTM: | 553% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -4% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,718 |
| Reserves | -780 | -773 | -903 | -683 | 351 | 344 |
| 0 | 0 | 250 | 250 | 250 | 250 | |
| 891 | 1,322 | 1,983 | 2,799 | 3,891 | 4,840 | |
| Total Liabilities | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 7,151 |
| 39 | 46 | 49 | 52 | 58 | 0 | |
| CWIP | 2 | 2 | 1 | 4 | 1 | 0 |
| Investments | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 5,965 |
| 129 | 230 | 287 | 455 | 675 | 1,186 | |
| Total Assets | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 7,151 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 257 | 338 | 593 | 813 | ||
| -374 | -723 | -829 | -1,882 | ||
| 280 | 374 | 280 | 1,110 | ||
| Net Cash Flow | 164 | -12 | 43 | 41 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | |||||
| Days Payable | |||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -270 | -290 | -303 | -282 | -292 |
| ROCE % | -10% | -30% | 1% | 5% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
27m - Of Earnings call on the Audited Financial Results for the quarter and financial year ended March 31, 2025.
-
Reporting Of Incidence Under The SEBI (Prohibition Of Insider Trading) Regulations, 2015
22h - Multiple insider trading violations reported; penalties and warnings issued, largest trade ₹10.08 million without pre-clearance.
-
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31, 2025
1d - Board meeting on May 7 to approve audited results for FY ended March 31, 2025; trading window closed till May 9.
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 24 Apr
-
Update On Re-Appointment Of Mr. Krishnan Ramachandran As CEO & Managing Director
23 Apr - IRDAI approved re-appointment of CEO Krishnan Ramachandran for five years from May 1, 2025.
Concalls
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
Leading Insurance Company[1] Niva Bupa is the 3rd largest and the 2nd fastest growing standalone health insurer (SAHI) in India based on overall health gross direct premium income (GDPI) of Rs 5,494.43 crore in FY24 with an overall market share of 5.1%.